Fas-mediated upregulation of vascular endothelial growth factor and monocyte chemoattractant protein-1 expression in cultured dermal fibroblasts: Role in the inflammatory response

Journal of Dermatology

Volumn 34, Issue 2, 2007, Pages 99-109

  Fujiwara, Masao ^a,b   Suemoto, Hiroki ^b   Muragaki, Yasuteru ^b   Ooshima, Akira ^b  

^a SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Dermal fibroblast; Fas; Monocyte chemoattractant protein 1; Vascular endothelial growth factor

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CYSTEINE PROTEINASE INHIBITOR; DNA FRAGMENT; FAS ANTIBODY; FAS ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL INFILTRATION; CELL TRANSPLANTATION; CHEMOTAXIS; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; SKIN CELL; SKIN NODULE; UPREGULATION;

ANIMALS; APOPTOSIS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; DERMIS; FAS LIGAND PROTEIN; FIBROBLASTS; HUMANS; IN SITU NICK-END LABELING; INFLAMMATION; MACROPHAGES; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846188921     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2006.00226.x     Document Type: Article

References (32)

1. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747-1756.
2. Oishi M, Maeda K, Sugiyama S. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch Dermatol Res 1994; 286: 396-407.
3. Santiago B, Galindo M, Palao G, Pablos JL. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide. J Immunol 2004; 172: 560-566.
4. Aggarwal BB, Singh S, LaPushin R, Totpal K. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett 1995; 364: 5-8.
5. Freiberg RA, Spencer DM, Choate KA et al. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J Invest Dermatol 1997; 108: 215-219.
6. Jelaska A, Korn JH. Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J Cell Physiol 1998; 175: 19-29.
7. Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998; 30: 1019-1030.
8. Biancone L, Martino AD, Orlandi V, Conaldi PG, Toniolo A, Camussi G. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J Exp Med 1997; 186: 147-152.
9. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56: 549-580.
10. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
11. Dewald O, Zymek P, Winkelmann K et al. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 2005; 96: 881-889.
12. Reckless J, Rubin EM, Verstuyft JB, Metcalfe JC, Grainger DJ. Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions. Circulation 1999; 99: 2310-2316.
13. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-521.
14. Kim EJ, Sampathkumar SG, Jones MB et al. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl-and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells. J Biol Chem 2004; 279: 18342-18352.
15. Fujiwara M, Muragaki Y, Ooshima A. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 2005; 297: 161-169.
16. Form DM, Pratt BM, Madri JA. Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab Invest 1986; 55: 521-530.
17. Solowiej A, Biswas P, Graesser D, Madri JA. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 2003; 162: 953-962.
18. Medema JP, Scaffidi C, Kischkel FC et al. flice is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997; 16: 2794-2804.
19. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000; 157: 1415-1430.
20. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-11556.
21. Appleton I, Brown NJ, Willoughby DA. Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 1996; 149: 1441-1447.
22. Akasaka Y, Ito K, Fujita K et al. Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase-9 activation during the apoptosis of keloid fibroblast lines. Wound Repair Regen 2005; 13: 373-382.
23. Moodley Y, Rigby P, Bundell C et al. Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36. Am J Pathol 2003; 162: 771-779.
24. Haake AR, Polakowska RR. Cell death by apoptosis in epidermal biology. J Invest Dermatol 1993; 101: 107-112.
25. Schaub FJ, Han DK, Liles WC et al. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 2000; 6: 790-796.
26. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med 2005; 11:725-730.
27. Moldovan L, Moldovan NI. Role of monocytes and macrophages in angiogenesis. EXS 2005; 94: 127-146.
28. Dipietro LA, Reintjes MG, Low QE, Levi B, Gamelli RL. Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. Wound Repair Regen 2001; 9: 28-33.
29. Kurihara T, Bravo R. Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J Biol Chem 1996; 271: 11603-11607.
30. Zachariae CO, Anderson AO, Thompson HL et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 1990; 171: 2177-2182.
31. Van Damme J, Proost P, Lenaerts JP, Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992; 176: 59-65.
32. Ernst CA, Zhang YJ, Hancock PR, Rutledge BJ, Corless CL, Rollins BJ. Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. J Immunol 1994; 152: 3541-3549.